seekingalpha.com
/1 month ago
Latest updates for Aytu
Fresh curated links around AYTU are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Aytu BioPharma, Inc. (AYTU) Q4 2026 Earnings Call Transcript
- Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results
- Aytu outlines $49M-$54M FY27 operating expense plan as it targets 66%-67% gross margin in Q4 FY27
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
newswire.com
/1 month ago
Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results
Fourth quarter fiscal 2026 net revenue increased 6.4% to $16.1 million from $15.1 million in the prior-year quarterFourth quarter fiscal 2026 Adjusted EBITDA of $0.5 millionEXXUA n...
seekingalpha.com
/1 month ago
Aytu outlines $49M-$54M FY27 operating expense plan as it targets 66%-67% gross margin in Q4 FY27
newswire.com
/1 month ago
Aytu BioPharma to Report Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results on September 22, 202...
seekingalpha.com
/2 weeks ago
Artrya Limited (AYAUF) Discusses Commercial Agreement With Huntsville Hospital Health System and Strategic Go-To-Market...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Aytu
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
newswire.com
Recent coverage from public sources
Public source